
10,000 Patients Enrolled in Kenya’s Fight Against Chronic Diseases
The Access to Healthcare program by Boehringer Ingelheim, a research-driven biopharmaceutical company, in partnership with mPharma, has recently enrolled over 10,000 patients in long-term care for hypertension and type 2 diabetes. In…






















